GreenClinic LifeScience
GreenClinic LifeScience delivers applied ecosystem phytopathology and soil microbiome testing services using metagenomics and an AI-powered knowledge base, serving large agribusinesses, forestry operators, municipalities, and residential plant owners globally via custom contract research and licensed partners.
- Company typePrivate
- Founded2015
- HeadquartersKraków, Poland
- Headcount11–50
- GTM typeB2B
- OfferingServices
What GreenClinic LifeScience does
GreenClinic LifeScience (GCLS) operates as an independent international competence center delivering applied ecosystem, biodiversity, and plant pathology services based on metagenomics, data science, and an AI-powered knowledge base. The company is a subsidiary brand within the GNerdiX OÜ group following a 2022 rebranding, with its primary legal entity being GreenClinic LifeScience Ukraine, LLC (Registry Code 40569905), plus entities in Poland (GreenClinic LifeScience Sp. z o.o.) and Estonia. Its flagship technical product is BioFiling™, a DNA-based soil and plant microbiome profiling test positioned as the world's first standard analysis for routine soil biological fertility testing, developed 2009–2015 and launched commercially in 2019. The service portfolio includes Preventive Ecosystem Phytopathology 360° (HACCP-based), Global Ecosystem Phytopathology Service, Plant Clinic – Plants' Health Care 360°, e-Phytopathology (electronic advisory opinions), Phytopathological Forensic (root cause analysis), Right Seeds 2 Right Fields (pre-seed DNA pathogen profiling for crop variety selection), and broader biodiversity research and climate change adaptation services.
Revenue is generated through professional services contracts — custom contract research, on-site examinations, advisory opinions, and BioFiling™ microbiome testing — delivered under quote-based, multi-year contracts. The customer base is diversified across large agribusinesses, forestry operators, municipalities, landscapers, and residential plant owners, with large enterprise customers served directly and retail/small customers reached through an international network of owned and partnered Centers of Ecosystem Phytopathology (plant clinics). The company also operates infrastructure platforms including HUBBSA, an 80-hectare research hub and experimental farm station in Ukraine, and GreenClinic LifeScience Academy, an educational platform.
GreenClinic LifeScience firmographics
Firmographics- Name
- GreenClinic LifeScience
- Legal name
- GreenClinic LifeScience Ukraine, LLC
- Website
- https://greenclinicglobal.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- GreenClinic LifeScience delivers applied ecosystem phytopathology and soil microbiome testing services using metagenomics and an AI-powered knowledge base, serving large agribusinesses, forestry operators, municipalities, and residential plant owners globally via custom contract research and licensed partners.
- Ownership category
- akta.pro rank
GreenClinic LifeScience industry classification
Industry- Product category
- Plant Pathology & Soil Microbiome Services
- NAICS
- Soil Preparation, Planting, and Cultivating (115112), Environmental Consulting Services (541620)
- SIC
- Agricultural Services (700), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Soil Health & Biological Testing Services (Microbial Activity, Organic Matter, Respiration) (AFACAKAD)
- akta.pro secondary industries
- Microbiome & Metagenomics Services (HLAGANAH), Nutrient Stewardship & Soil Fertility Management (4R Nutrients, Compost, Biofertilizers) (AFAGAMAE), Carbon, Sustainability & Farm Certification Support (Agro-Environmental Advisory) (AFACABAL)
Keywords
Where GreenClinic LifeScience is headquartered
LocationHeadquarters
- HQ city
- Kraków
- HQ country
- Poland
- HQ region
- Europe
Offices2 records
Markets served
GreenClinic LifeScience business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Ecosystem Phytopathology Research Services: Contract research services for plant pathology support including on-site examinations documented in protocols, advisory opinions with recommendations and action plans. Services provided globally to agribusinesses, forestry, and landscaping customers.
- Soil & Plants Microbiome Testing Services: DNA-based microbiome profiling analysis services including BioFiling™ standard test and tailor-made orders for applied microbiome research. Provides soil biological fertility testing and BioFiling Plants for pathogen definition inside plants.
- Scientific Decision Support Services: Custom contract researches and research products tailored to cover the need for reliable high quality data and expert support for decision making and implementation. Covers bioeconomy, agriculture, medicine, wellbeing, safety, sustainable infrastructure and renewables.
- Right Seeds 2 Right Fields Service: High precision choice of crop varieties and hybrids for field growing conditions based on resistance profile matching phytopathological threat profiles of fields.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom service pricing based on client requirements and project scope |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
GreenClinic LifeScience product offering
Product offeringCore offering
GreenClinic LifeScience delivers Ecosystem Phytopathology as a Service, providing DNA-based soil and plant microbiome profiling (BioFiling™), plant disease diagnostics, preventive ecosystem phytopathology advisory, biodiversity research, and phytopathological forensic services. Its customers are agribusinesses, foresters, landscaping and municipal green-services operators, and households seeking independent, science-driven plant and soil health expertise.
Product overview
GreenClinic LifeScience operates as an independent international competence center delivering industrial value through applied ecosystem, biodiversity, and plant pathology knowledge based on metagenomics and data science. The core offering centers on Ecosystem Phytopathology as a Service, comprising BioFiling™ Soil and Plants Microbiome Profiling Test (the world's first standard for routine soil biological fertility testing) as the foundational diagnostic tool. This is supported by preventive and reactive plant health services including Plant Clinic – Plants' Health Care 360°, Global Ecosystem Phytopathology Service, and e-Phytopathology electronic advisory platform. The Right Seeds 2 Right Fields pre-seed DNA pathogen profiling enables precision agriculture decisions. The company also maintains research infrastructure platforms including HUBBSA (80-hectare experimental farm), Urban Biodiversity Research Center, and a network of Centres for Ecosystem Phytopathology. Additional services span climate change adaptation, biodiversity research for construction, scientific decision support, and the GreenClinic LifeScience Academy educational platform. The portfolio is tied together by an AI-powered knowledge base and biodata processing system.
Differentiator
Problem solved
Functional benefit
Brands
- BioFiling™: World's first standard analysis for routine soil biological fertility testing, a DNA-based soil micro biodiversity analysis delivering wide, detailed and precise soil microbiota profile.
- e-Phytopathology
- EVIM
- WasteInForum
Products and services
- BioFiling™ Soil and Plants Microbiome Profiling Test
Quantifiable outcome
- 78% higher profits with regenerative agriculture according to research by Claire LaCanne and Dr. Jonathan Lundgren
- +1 more outcomes
Companies that use GreenClinic LifeScience
Customer profileSegments4 records
Ideal customer profiles2 records
GreenClinic LifeScience technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
GreenClinic LifeScience partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- GNerdiX OÜcoreGNerdiX OÜ (Estonia) founded HUBBSA research hub and is the parent company following rebranding of GreenClinic LifeScience Global OÜ. GNerdiX represents the brands internationally and backs GNerdiX projects with research infrastructure.
- HUBBSA Partner FarmscoreTwo partner farms uniquely located in the forest steppe and steppe zones, directly neighboring each other, 100km south of Kyiv Boryspil Airport. Support HUBBSA experimental farm station operations.
- GreenClinic LifeScience Ukraine, LLCcoreR&D and project management center located in Kyiv, Ukraine. Founded by initiative of GreenClinic LifeScience and GNerdiX OÜ. Represents brands in Ukraine, manages national market operations, maintains research infrastructure.
Scale indicators3 records
Recent moves7 records
Expansion highlights6 records
GreenClinic LifeScience competitors and assessment
Company assessmentBroad incumbents
- AgBiome: AgBiome is an established agricultural biologicals and crop protection company using microbial discovery; its platform overlaps with GCLS's microbiome-informed plant health advisory.
- SGS SA: SGS operates a global agricultural testing and inspection network including soil and plant health services, comparable to GCLS as a contract research/testing provider serving agribusiness and forestry.
- Eurofins Scientific: Eurofins is a global contract testing and laboratory services group with agricultural soil, plant and microbiome testing capabilities, comparable as a scaled commercial research provider to GCLS's contract research offerings.
- Indigo Ag: Indigo Ag is a larger digital agriculture and microbial products platform; its soil health and microbiome-enabled agronomy offerings overlap with GCLS's biotech-driven crop advisory services.
- Bayer Crop Science: Bayer Crop Science is a major incumbent in crop protection, seeds and digital farming (Climate FieldView), broadly overlapping with GCLS's agribusiness and digital decision-support positioning.
Direct peers
- Pattern Ag: Pattern Ag analyzes soil and crop microbiomes with metagenomics to predict pest and pathogen pressure, closely paralleling GCLS's Right Seeds 2 Right Fields and Phytopathological Forensic services.
- Trace Genomics: Trace Genomics provides soil DNA sequencing and analytics for agribusinesses and agronomists, overlapping directly with GCLS's microbiome-based crop diagnostics and field decision-support offerings.
- Biome Makers: Biome Makers applies DNA sequencing and AI to soil microbiome analysis for agriculture (BeCrop®), directly mirroring GCLS's BioFiling™ DNA-based soil biodiversity profiling and agronomic advisory positioning.
Emerging players
- Concentric Ag: Concentric Ag develops microbial products and soil-health analytics leveraging root and soil microbiome science, overlapping with GCLS's biological-soil-fertility and microbiome diagnostics work.
Regional players
- NRGene: NRGene provides genomics and bioinformatics for crop breeding and ag-input companies, technologically comparable to GCLS's metagenomics/DNA-based analytics though focused on genomics rather than soil microbiome diagnostics.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
GreenClinic LifeScience social profiles
Digital presenceGreenClinic LifeScience financial estimates
Financial estimateRevenue estimate
Valuation estimate
GreenClinic LifeScience leadership team
Management profileNumber of profiles
Profiles2 records
GreenClinic LifeScience subsidiaries and ownership
Company hierarchySubsidiaries2 records
GreenClinic LifeScience funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GreenClinic LifeScience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GreenClinic LifeScience
What does GreenClinic LifeScience do?
GreenClinic LifeScience delivers Ecosystem Phytopathology as a Service, providing DNA-based soil and plant microbiome profiling (BioFiling™), plant disease diagnostics, preventive ecosystem phytopathology advisory, biodiversity research, and phytopathological forensic services. Its customers are agribusinesses, foresters, landscaping and municipal green-services operators, and households seeking independent, science-driven plant and soil health expertise.
Is GreenClinic LifeScience a public or private company?
GreenClinic LifeScience is a private company. It is classified as corporate owned and is currently operating.
When was GreenClinic LifeScience founded?
GreenClinic LifeScience was founded in 2015. It employs 11 to 50 people.
Where is GreenClinic LifeScience based?
GreenClinic LifeScience is headquartered in Kraków, Poland, in the Europe region.
How does GreenClinic LifeScience make money?
Four revenue lines are on record. Ecosystem Phytopathology Research Services are the primary driver. The others are soil & Plants Microbiome Testing Services, scientific Decision Support Services and right Seeds 2 Right Fields Service.
Who are GreenClinic LifeScience's main competitors?
Broad incumbents on record are AgBiome, SGS SA, Eurofins Scientific, Indigo Ag and Bayer Crop Science. Direct peers are Pattern Ag, Trace Genomics and Biome Makers. Concentric Ag is listed as an emerging player. NRGene is listed as a regional player.
Does GreenClinic LifeScience have an API?
No public API is recorded for GreenClinic LifeScience.
What industry is GreenClinic LifeScience in?
GreenClinic LifeScience's product category is Plant Pathology & Soil Microbiome Services. Its primary akta.pro industry code is AFACAKAD, Soil Health & Biological Testing Services (Microbial Activity, Organic Matter, Respiration), with a secondary code of HLAGANAH, Microbiome & Metagenomics Services. Its NAICS code is 115112 and its SIC code is 700.